| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/11/2009 | CA2716951A1 Raf inhibitor compounds and methods of use thereof |
| 09/11/2009 | CA2716949A1 N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer |
| 09/11/2009 | CA2716947A1 Imidazo [4,5-b] pyridine derivatives used as raf inhibitors |
| 09/11/2009 | CA2716863A1 Sub-type selective amides of diazabicycloalkanes |
| 09/11/2009 | CA2716851A1 Combination therapy with c-met and egfr antagonists |
| 09/11/2009 | CA2716838A1 Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same |
| 09/11/2009 | CA2716767A1 Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide |
| 09/11/2009 | CA2716706A1 Compounds and compositions as tlr activity modulators |
| 09/11/2009 | CA2716664A1 Oxadiazoanthracene compounds for the treatment of diabetes |
| 09/11/2009 | CA2716576A1 Fulvestrant formulations |
| 09/11/2009 | CA2716518A1 Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
| 09/11/2009 | CA2716413A1 Crystal form of phenylamino pyrimidine derivatives |
| 09/11/2009 | CA2716352A1 Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| 09/11/2009 | CA2716136A1 Hexahydrocyclopentyl[f]indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators |
| 09/11/2009 | CA2716130A1 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor |
| 09/11/2009 | CA2716122A1 2-aminoquinolines |
| 09/11/2009 | CA2715842A1 2-aminoquinoline derivatives |
| 09/11/2009 | CA2715811A1 Methods of increasing epidermal skin thickness by topical administration of a 19-nor containing vitamin d compound |
| 09/11/2009 | CA2715796A1 2-aryl and 2 -heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain |
| 09/11/2009 | CA2715685A1 Pharmaceutical solutions, process of preparation and therapeutic uses |
| 09/11/2009 | CA2715437A1 Pyridin-2-yl derivatives as immunomodulating agents |
| 09/11/2009 | CA2715317A1 Novel aminomethyl benzene derivatives |
| 09/11/2009 | CA2715065A1 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression mcp-1 and cx3cr1 |
| 09/11/2009 | CA2714665A1 Pyridine compounds |
| 09/11/2009 | CA2714617A1 Alkylaminopyridine derivative |
| 09/11/2009 | CA2714614A1 Novel pyrimidine-pyridine derivatives |
| 09/11/2009 | CA2714441A1 Crystal forms of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation |
| 09/11/2009 | CA2714436A1 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/11/2009 | CA2713989A1 Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimens |
| 09/11/2009 | CA2712921A1 Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof |
| 09/11/2009 | CA2712703A1 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/11/2009 | CA2712403A1 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/11/2009 | CA2711247A1 2-aminoquinolines |
| 09/10/2009 | US20090229015 Schizochytrium Fatty Acid Synthase (FAS) and Products and Methods Related Thereto |
| 09/10/2009 | US20090228998 Induction of exon skipping in eukaryotic cells |
| 09/10/2009 | US20090228997 Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereof |
| 09/10/2009 | US20090227976 Multiple biocompatible polymeric strand aneurysm embolization system and method |
| 09/10/2009 | US20090227809 New 2-(alpha-hydroxypentyl) benzoates, their preparations and their uses |
| 09/10/2009 | US20090227802 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof |
| 09/10/2009 | US20090227798 Novel processes for the preparation of (r)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 09/10/2009 | US20090227776 Compositions and methods for the diagnosis and treatment of tumor |
| 09/10/2009 | US20090227688 Admixture of carotenoids having provitamin a activity and carotenoids devoid of provitamin a activity for treating aging symptoms |
| 09/10/2009 | US20090227686 Methods of preventing, treating and diagnosing disorders of protein aggregation |
| 09/10/2009 | US20090227683 Compositions for Providing an Analgesic Effect to the Skin |
| 09/10/2009 | US20090227682 Xetine compositions |
| 09/10/2009 | US20090227681 Polymorphic form of n-(s)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl) cyclopropane-1-sulfonamide and uses thereof |
| 09/10/2009 | US20090227680 Amino Acid Derivatives |
| 09/10/2009 | US20090227679 Novel NIDDM Regimen |
| 09/10/2009 | US20090227678 Process for obtaining lipid form cells |
| 09/10/2009 | US20090227677 Low Dose Lipoic Acid Pharmaceutical Compositions and Methods |
| 09/10/2009 | US20090227676 Methods and compositions for treating cancer |
| 09/10/2009 | US20090227674 Combination methods fo saha and targretin for treating cancer |
| 09/10/2009 | US20090227673 Method and Composition for the Treatment of Parkinson's Disease |
| 09/10/2009 | US20090227672 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 09/10/2009 | US20090227671 Prevention and treatment of atherosclerosis with lithospermate B |
| 09/10/2009 | US20090227670 antiviral fragrances for reduction of viruses causing common cold |
| 09/10/2009 | US20090227669 Compositions and Methods for Perioperative Bladder Instillation |
| 09/10/2009 | US20090227668 Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
| 09/10/2009 | US20090227667 5'-chloro-N-[3,3,3-trifluoro-2-(trifluoromethyl)-1S-(hydroxymethyl)propyl]thiophene-2'-sulfonamide, used for the treatment of Alzheimer's Disease and Down's syndrome |
| 09/10/2009 | US20090227666 Enhancing Disease Resistance In An Animal |
| 09/10/2009 | US20090227665 Methods and Compositions For The Prevention and Treatment of Kidney Disease |
| 09/10/2009 | US20090227664 Expression Vectors Able to Elicit Improved Immune Response and Methods of Using Same |
| 09/10/2009 | US20090227663 Inhibition of tumor growth and invasion by anti matrix metalloproteinases dnazymes |
| 09/10/2009 | US20090227662 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 09/10/2009 | US20090227661 Transcription factor decoy oligodeoxynucleotides having multiple cis elements |
| 09/10/2009 | US20090227659 Nucleolar targeting of therapeutics against HIV |
| 09/10/2009 | US20090227658 Methods and compositions for immunization against hiv |
| 09/10/2009 | US20090227657 Selective inhibition of pro-angiogenic VEGF pathway gene expression; Tissue targeted nanoparticle compositions comprising polymer (histidine-lysine copolymer) conjugates and nucleic acid molecules; antisense strand consists of the complement of SEQ ID NO: 286; ocular disease, arthritis, inflammation |
| 09/10/2009 | US20090227656 Methods for using modulators of proline-rich tyrosine kinase 2 |
| 09/10/2009 | US20090227655 Nonviral vectors for delivering polynucleotides to target tissue |
| 09/10/2009 | US20090227654 Modulation of Neuroglia-Derived BDNF in the Treatment and Prevention of Pain |
| 09/10/2009 | US20090227653 Substituted gamma lactams as therapeutic agents |
| 09/10/2009 | US20090227652 Indole derivatives and methods of using the same |
| 09/10/2009 | US20090227651 Preventive and/or therapeutic agent for urine collection disorder accompanying lower urinary tract obstruction |
| 09/10/2009 | US20090227650 Novel crystalline forms of Lestaurtinib |
| 09/10/2009 | US20090227649 Management of Ophthalmologic Disorders, Including Macular Degeneration |
| 09/10/2009 | US20090227648 Pyrazole derivatives useful for the treatment of cancer |
| 09/10/2009 | US20090227647 Compounds, Compositions and Methods for the Treatment of Islet Amyloid Polypeptide (IAPP) Accumulation in Diabetes |
| 09/10/2009 | US20090227646 Compositions Comprising Nebivolol |
| 09/10/2009 | US20090227645 Pharmaceutical compositions of valdecoxib |
| 09/10/2009 | US20090227644 Agent for regeneration and/or protection of nerves |
| 09/10/2009 | US20090227643 3-benzyloxycarbonylmethyl-4,5-dimethyl-thiazole-3-bromide, used for improving skin elasticity or reducing wrinkles, treating diabetes, kidney damage, hypertension, vision defects, neuropathy, osteoarthritis or in teeth antisoilants and preservatives |
| 09/10/2009 | US20090227642 Novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
| 09/10/2009 | US20090227641 Cycloalkylamino acid derivatives |
| 09/10/2009 | US20090227640 Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases |
| 09/10/2009 | US20090227639 Human protein tyrosine phosphatase inhibitors and methods of use |
| 09/10/2009 | US20090227638 Novel Pharmaceutical Compounds |
| 09/10/2009 | US20090227637 Diaryl ureas for treating virus infections |
| 09/10/2009 | US20090227636 substituted pyrrolidine derivatives, used for the treatment vision defects such as glaucoma or ocular hypertension |
| 09/10/2009 | US20090227635 Therapeutic compounds |
| 09/10/2009 | US20090227634 Pyrazole Derivatives as 5-LO-Inhibitors |
| 09/10/2009 | US20090227633 Methods to inhibit tumor cell growth by using proton pump inhibitors |
| 09/10/2009 | US20090227632 Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin reuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor |
| 09/10/2009 | US20090227631 2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors |
| 09/10/2009 | US20090227630 Pharmaceutical Composition Achieving Excellent Absorbency of Pharmacologically Active Substance |
| 09/10/2009 | US20090227629 Compounds having activity at the glycine transporter glyt1 and uses thereof |
| 09/10/2009 | US20090227628 2-aminoquinolines |
| 09/10/2009 | US20090227627 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of beta-secretase (bace) |
| 09/10/2009 | US20090227626 Novel polyquinoline derivatives and therapeutic use thereof |
| 09/10/2009 | US20090227625 Cxcr2 inhibitors |